Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases. - Wikidata - wikimedia - TriplyDB

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.

http://www.wikidata.org/entity/Q37089475

about

Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Invasive candidiasis: future directions in non-culture based diagnosis.A Potential Explanation of a Positive Serum β-Glucan Assay in Mucormycosis.Diagnostic performance of the (1-3)-β-D-glucan assay in patients with Pneumocystis jirovecii compared with those with candidiasis, aspergillosis, mucormycosis, and tuberculosis, and healthy volunteers.Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy.Use of 1,3-β-D-glucan in invasive fungal diseases in hematology patients.T2 Magnetic Resonance Assay: Overview of Available Data and Clinical Implications.

P2860

Q30235457-68EE0819-8DEF-43E3-A48D-CDFB3DC1D925 Q38614492-EE4730A1-330C-4B40-8D46-7AF8E981D08E Q40413734-50E12428-7032-4E04-B5D0-AFF49D3670E3 Q47114916-2D0CADA6-E690-4465-82EB-E478ED0DF224 Q47330011-A68BBA0D-3FAD-4EC1-908C-5D88A0740EFB Q50072321-3DED31BA-C50F-43F8-9661-2AE2425D8CCD Q55437393-B4FB1EE0-3181-49E6-B78C-78D32DF08643

P2860

Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases.

http://www.wikidata.org/entity/Q37089475

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@en

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@nl

type

label

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@en

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@nl

prefLabel

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@en

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@nl

P1433

Q37089475-3D172BF5-561D-4BFE-9E8B-2E6EEAD368FD

P1476

Q37089475-D926CDAC-7CA8-46D7-9C31-4A6690505134

P2093

Q37089475-072440FA-0F44-4463-9771-DEE20493487C

Q37089475-1519F785-2041-4FAE-B5E8-57ADE9E80CBA

Q37089475-1B7F9654-17FD-4BAC-A93C-4C25DB2949DE

Q37089475-3ED7B583-281B-4A60-897D-B721405E4DEE

Q37089475-613076FC-A533-4A71-8ECF-C1266680BB46

Q37089475-6CCE0461-B71A-48E5-ACE7-B3C226B9D898

Q37089475-8758DB2D-4BBD-4C56-819F-35D2F4EEA56C

Q37089475-908FF1FD-B89F-42F7-9746-41851625B7F9

Q37089475-90ED2FCA-B5B7-4CB3-A6F3-8E46918FE0BF

Q37089475-AAEB8D9D-1033-4DAB-A3F7-F22086261058

P2860

Q37089475-0460C8CC-8EBC-4B45-8629-2FE51B24049F

Q37089475-04B0AB47-710A-4E7D-9CD8-38697D588305

Q37089475-1CF3A386-BBE5-44C4-A939-0A4083F1BBFE

Q37089475-20D834CF-5E11-468B-BACC-C1449895A28E

Q37089475-23736950-6F4C-48E7-8E95-200DB502DE11

Q37089475-244AE38E-1ABA-487E-ADC8-E8A535C8909E

Q37089475-25C29516-950D-4A18-8AA4-272BF62849BF

Q37089475-25D87506-6CDA-4F5D-A642-BE6F6324F126

Q37089475-3335205C-54CE-4177-BD9C-68FD41CBF704

Q37089475-3534734C-3BA4-4EC5-9B98-1930D9170AF8

P304

Q37089475-278FDE10-B0DE-4F1F-9E71-8EF861C74ECB

P31

Q37089475-EAD6FF07-84EA-47F1-81AD-DA676003C46B

P356

Q37089475-B1BEBCCF-4823-4828-A7B4-C92099510651

P433

Q37089475-8A1232F2-BE63-4037-9F32-A106B0647C33

P478

Q37089475-035370B5-6AA4-4FE0-A77D-955DF9C4E168

P50

Q37089475-131EB577-33A7-484B-9901-FFAE5C0593E0

Q37089475-CBA8EBF1-3234-4175-85D3-C8EE72925C54

P577

Q37089475-4FFABBFE-F428-4931-8927-67780E5F69F1

P698

Q37089475-F50DAA98-BC49-4C3E-90DD-A387C27ACF11

P932

Q37089475-FCF1BAE6-F08B-4ECA-8143-1B36EDF485CF

P356

P1433

Open forum infectious diseases

P1476

Prospective Evaluation of Seru ...... ble or Proven Fungal Diseases.

@en

P2093

Anne Scemla

http://www.w3.org/2001/XMLSchema#string

Anne-Laure Roupie

http://www.w3.org/2001/XMLSchema#string

Aurélie Agathine

http://www.w3.org/2001/XMLSchema#string

Aurélie Dupuis

http://www.w3.org/2001/XMLSchema#string

Bénédicte Neven

http://www.w3.org/2001/XMLSchema#string

Cécile Angebault

http://www.w3.org/2001/XMLSchema#string

Cécile Schrimpf

http://www.w3.org/2001/XMLSchema#string

Denis Caillot

http://www.w3.org/2001/XMLSchema#string

Etienne Paubelle

http://www.w3.org/2001/XMLSchema#string

Fanny Lanternier

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.

Population-based analysis of invasive fungal infections, France, 2001-2010.

High Levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease.

Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients.

Last generation triazoles for imported eumycetoma in eleven consecutive adults

Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting

Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients

Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis

P304

ofw128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/OFID/OFW128

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Lortholary

Christophe d'Enfert

P577

2016-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27419189

http://www.w3.org/2001/XMLSchema#string

P932

4942764

http://www.w3.org/2001/XMLSchema#string